Charlie White, MS

Research Biostatistician
Memorial Sloan Kettering Cancer Center
New York, New York, United States

Disclosure information not submitted.

Presentation(s):

• Paper 22 - A MULTI-CENTER PHASE II STUDY OF THE ANTI-GD2 HUMANIZED MONOCLONAL ANTIBODY NAXITAMAB IN COMBINATION WITH GM-CSF IN RECURRENT OSTEOSARCOMA.

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST